ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,764Medicare Part D Prescriptions Filled, Including Refills

Rank: 272 out of 1111

$395K Total Retail Price of All Prescriptions

Rank: 337 out of 1111

132 Patients Receiving at Least One Drug in Part D
56%Patients 65 Years and Older
59% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

37% of this provider’s 132 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

3% of this provider’s 4,402 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

59 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
KLOR-CON 8 414 254 10 1 120
SYNTHROID 340 221 2 63
OMEPRAZOLE 299 160 3 4
FUROSEMIDE 275 188 4 6
GABAPENTIN 253 121 5 10
CRESTOR 229 133 6 33
HYDROCODONE-ACETAMINOPHEN 215 69 S3 7 1
SIMVASTATIN 205 143 8 5
LOSARTAN POTASSIUM 196 124 9 34
ENALAPRIL MALEATE 174 103 10 56
TRAZODONE HCL 142 55 11 32
INSULIN SYRINGE 136 86 12 167
ACETAMINOPHEN-CODEINE 129 51 S3 13 140
HYDROCHLOROTHIAZIDE 117 73 14 11
METOPROLOL TARTRATE 108 56 15 12
RANITIDINE HCL 107 51 16 29
FLUNISOLIDE 106 80 17 201
SERTRALINE HCL 106 52 17 24
MELOXICAM 104 59 19 18
BETAMETHASONE VALERATE 102 42 20 327
METFORMIN HCL 96 51 21 8
ZOLPIDEM TARTRATE 92 41 22 16
TRAMADOL HCL 89 39 23 13
ATENOLOL 88 50 24 22
AFEDITAB CR 85 62 25 313
LOVAZA 79 36 26 184
FLUOXETINE HCL 78 31 27 44
GEMFIBROZIL 77 36 28 92
AMLODIPINE BESYLATE 76 35 29 7
MENEST 76 43 R 10 29 274
COUMADIN 75 19 31 233
CLONIDINE HCL 73 34 32 42
AMITRIPTYLINE HCL 73 40 R 32 64
NAPROXEN 70 56 34 85
CITALOPRAM HBR 68 27 35 14
PROMETHAZINE HCL 67 27 R 36 69
COMBIVENT 66 64 37 129
LISINOPRIL 64 60 38 2
DIVALPROEX SODIUM 61 43 39 82
ALLOPURINOL 58 39 40 36
LACTULOSE 58 30 40 166
BACLOFEN 56 40 42 119
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 30, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.